IPO - Healthcare Triangle, Inc.

Form Type: 424B4

Filing Date: 2025-05-15

Corporate Action: Ipo

Type: New

Accession Number: 000121390025044095

Filing Summary: Healthcare Triangle, Inc. is offering up to 1,483,809,885 shares of Common Stock through selling stockholders as outlined in this prospectus, registered under Rule 424(b)(4). The offering includes shares acquired by selling stockholders from securities purchase agreements dated February 27, 2025, potential shares from pre-funded and Series A and B warrants, with specific conditions governing the exercise prices and obligations. The Series B warrants are notable for a 'zero exercise price option' feature which may result in significant dilution to existing stockholders. The document emphasizes the company’s strategy, which combines proprietary technology platforms and industry expertise to support healthcare organizations. Furthermore, it highlights the various compliance measures in place, supports customer engagement, and underscores partnerships with major cloud providers. The company does not anticipate cash proceeds from the Series B warrants due to the incentives for holders to opt for the increased shares under the zero exercise option. This IPO aims to attract investors eager to support the company’s growth in healthcare technology and life sciences, while also informing about risks associated with this investment.

Form Type: S-1/A

Filing Date: 2025-05-09

Corporate Action: Ipo

Type: Update

Accession Number: 000121390025041190

Filing Summary: Healthcare Triangle, Inc. is filing Amendment No. 2 to its Form S-1 Registration Statement to provide a detailed prospectus concerning the offer and sale of up to 1,483,809,885 shares of common stock by selling stockholders. The common stock will be offered at market prices or negotiated prices. This amendment is being filed as the company continues its process towards an initial public offering (IPO). The company emphasizes its role as a healthcare information technology provider focused on cloud services, data science, and managed services within the healthcare and life sciences sectors. The document highlights essential offerings such as proprietary technology platforms (CloudEz and DataEz) aimed at enhancing health outcomes through advanced analytics, AI/ML, and extensive industry knowledge. The filing includes information on the company’s securities offerings, warrants, and the obligations related to registration rights agreements, alongside risk factors pertinent to potential investors. The registration of shares is aimed at satisfying obligations to selling stockholders and does not involve the company selling its shares directly or receiving proceeds from those sales. Regulatory compliance, emerging growth company status, and operational capabilities are also discussed in detail, underscoring Healthcare Triangle, Inc.'s commitment to providing innovative healthcare solutions and technologies.

Form Type: S-1/A

Filing Date: 2025-04-22

Corporate Action: Ipo

Type: Update

Accession Number: 000121390025034248

Filing Summary: Healthcare Triangle, Inc. has filed Amendment No. 1 to its Form S-1 registration statement under the Securities Act of 1933, aimed at registering the offer and sale of up to 1,483,809,885 shares of common stock by selling stockholders. The shares consist of common stock purchased through Securities Purchase Agreements, and the potential issuance includes shares from exercising various warrants. The document indicates the offering is intended to satisfy registration rights, with the company itself not selling any shares nor receiving proceeds from these sales. The maximum cumulative issuance under the Purchase Warrants, notably the Series A and B warrants, is addressed, including the presence of an exercise price reset mechanism for the warrants. The registration is tagged as being under Rule 415 (delayed/continuous offering), and the company is categorized as a smaller reporting and emerging growth company. The document discusses their business model focused on cloud-based healthcare IT solutions, their partnerships, competitive positioning, and the nature of their services, reaffirming their operational strategy and market aims.

Form Type: S-1

Filing Date: 2025-04-01

Corporate Action: Ipo

Type: New

Accession Number: 000121390025027277

Filing Summary: Healthcare Triangle, Inc., a Delaware corporation, filed a registration statement on Form S-1 with the SEC on April 1, 2025. The document concerns the offer and sale of up to 1,483,809,885 shares of common stock by selling stockholders, which includes shares purchased under Securities Purchase Agreements and shares related to exercised warrants. The prospectus outlines that the company is not selling any shares and will not receive proceeds from the sales, though it will incur expenses related to registration. The intended commencement of the sale is as soon as the registration statement becomes effective. The company describes itself as a healthcare information technology firm focusing on cloud services and data solutions within the healthcare industry, emphasizing its technology platforms and managed services. It identifies as an emerging growth company and a smaller reporting company, which allows it to take advantage of reduced disclosure obligations. The common stock is listed on Nasdaq under the symbol HCTI, reflecting a closing price of $0.2996 on March 31, 2025.